Daniel R. Chevallard - 28 Sep 2021 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Michael Mueller, as Attorney-in-Fact
Issuer symbol
VIRX
Transactions as of
28 Sep 2021
Net transactions value
+$9,000
Form type
4
Filing time
29 Sep 2021, 18:04:18 UTC
Previous filing
01 Jun 2021
Next filing
29 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIRX Common Stock Options Exercise $9,000 +10,000 +18% $0.9000 66,760 28 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Options Exercise $0 -10,000 -10% $0.000000 88,817 28 Sep 2021 Common Stock 10,000 $0.9000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of July 30, 2019 (the "Vesting Commencement Date") and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, the last day of the month), subject to the reporting person continuing to be a Service Provider in accordance with Viracta Subsidiary, Inc.'s 2016 Equity Incentive Plan (the "Plan") through each such date.